InvestorsHub Logo

ATLnsider

11/27/22 12:46 AM

#539290 RE: Larppis #539289

Thank you for providing that link Larppis. The first link does specifically say Keytruda and Merck.

Did you watch and listen to the video? Did you also hear Dr. Liau say BMS (Bristol Meyers Squibb) around the 46:45 minute mark?
Bullish
Bullish

Smokey21

11/27/22 9:53 AM

#539350 RE: Larppis #539289

The first one is for Newly diagnosed GBM, the second is for Recurrent GBM. So, there are two different trials?

exwannabe

11/27/22 10:23 AM

#539357 RE: Larppis #539289

One link includes mention of the upcoming trial that will combine ATL-DC, PLX3397 and pembrolizumab.

The link that mentions the trial was updated a couple months ago, so I would take that as current.

The trial has not yet been posted on ct.gov, so no idea when, or if, it runs. There are some trials running that combine pembrollizumab and PLX3397.